Isolation and phenotypic characterization of human and nonhuman primate intestinal lamina propria mononuclear cells

Keltouma Benmeziane1, Benoit Delache1, Sébastien Langlois1

  • 1Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), 92265 Fontenay-aux-Roses and Le Kremlin-Bicêtre, France.

STAR Protocols
|January 3, 2023
PubMed

Insights

This study presents an optimized protocol for isolating high yields of viable intestinal lamina propria mononuclear cells (LPMCs) from human and nonhuman primate tissues. The method ensures repeatable and scalable cell isolation for further immune cell research.

Area of Science:

  • Immunology
  • Cell Biology
  • Gastroenterology

Background:

  • Characterizing immune cells in tissues is vital for understanding health and disease.
  • Intestinal lamina propria mononuclear cells (LPMCs) play key roles in gut immunity.

Purpose of the Study:

  • To provide an optimized protocol for high-yield isolation of viable LPMCs.
  • To detail methods for characterizing mononuclear phagocyte (MP) subtypes within LPMCs.

Main Methods:

  • Optimized protocol for intestinal tissue collection from humans and nonhuman primates.
  • Mechanical disruption and enzymatic digestion for cell isolation.
  • Flow cytometry analysis for mononuclear phagocyte (MP) subtype characterization.

Main Results:

  • Achieved high yields of viable intestinal lamina propria mononuclear cells (LPMCs).
  • Successfully characterized mononuclear phagocyte (MP) subtypes.
  • Protocol demonstrated repeatability and scalability.

Conclusions:

  • The optimized protocol facilitates robust isolation of viable LPMCs.
  • Enables detailed characterization of immune cell populations, particularly MPs.
  • Supports downstream applications in immunological and disease research.

Related Concept Videos